Arkolith/Insider Trading/HURA/Form 4

Dearborn Dan

Chief Financial OfficerTuHURA Biosciences, Inc./NV (HURA) · full profile →Form 4 · filed Nov 14, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 12, 2024Grant(A)490K—$0490K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-24-002164) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML